The Trump administration may not approve Florida’s drug import plan.
Review board’s new reference countries have more limited access to new and innovative drugs.
The original OHIP+ provided limited coverage to a population that largely didn’t need assistance.
U.S. pharmaceutical innovation has been disproportionately funded by U.S. consumers of patented drugs.
In most countries with universal health care, patients share the cost of treatment—surgical or pharmaceutical.
Under Medicare in the U.S., private insurers compete to offer coverage within regions.
Reform proposal misrepresents the nature of the global market and role of intellectual property.
Of the 53,109 ADR reports received in 2012, almost 80 per cent were categorized as “serious.”
Some Americans are ordering EpiPens from so-called “Canadian” Internet pharmacies.